Biotech Values

[DewDiligence]

Six biotech predictions for 2021:

1 $RVNC receives ~$5B buyout offer, which might not be accepted.
2 $ENTA gets out of penalty box by making progress in RSV &/or HBV.
3 $ABT continues 2b a great stock.
4 $PFE gains favor for Prevnar-20 prgrm.
5 $BMY does well b/c stock is dirt cheap.
6 $ICPT continues 2b dead $.

— Roy Friedman (@DewDiligence) January 1, 2021